BRAMLASDI

Registered
Word Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

MS

Owner Name

Type: Organization / Besloten Vennootschap (B.v.)

Address

Waarderweg 39
Haarlem, 2031BN
NL

Critical Dates

First Use Date

Not filed yet

Filing Date

Jun 27, 2025

Registration Date

Feb 10, 2026

Mark Descriptions

Goods

Class 5
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory...

Mark Elements

Text Mark
BRAMLASDI
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

Filing Date

Jun 27, 2025

Publication Date

Dec 23, 2025

Registration Date

Feb 10, 2026

USPTO Records

TitleDateCategorySourcePagesFormatActions

AI AssessmentCached Mar 12, 2026, 12:03 PM
Cached

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

Trademark Summary

BRAMLASDI is a standard character word mark covering pharmaceutical preparations in International Class 005 for treating and preventing a wide range of diseases and disorders, including bone, cardiovascular, neurological, oncological, and autoimmune conditions, along with antibiotics, antivirals, anti-inflammatories, and human vaccines; it spans domestic classes 005, 006, 018, 044, 046, 051, and 052. The mark is owned by Merck Sharp & Dohme B.V., a Netherlands-based BESLOTEN VENNOOTSCHAP (B.V.). It is currently registered on the Principal Register, with registration number 8134318 issued February 10, 2026. No notable issues or legal proceedings are present.

Recent Activity

The application was filed June 27, 2025, based on a Benelux priority registration (No. 1527162, September 16, 2025), followed by a suspension inquiry in September 2025 and a response in November 2025. It was approved for publication November 30, 2025, published for opposition December 23, 2025, and registered February 10, 2026.
USPTO
AI Analysis
v2.8.0
Generated Mar 12, 2026, 12:03 PM

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.